Molecular Pharmaceutics

SJR Rank #5,243H-index: 172SJR: 0.957Best quartile: Q1APC: US$4,500
Journal website: aims, scope and author guidelines
Publisher

American Chemical Society

Country

United States

Type

journal

SJR by Edition

2022202500.250.50.751

Subject Categories

  • Pharmaceutical ScienceQ1
  • Drug DiscoveryQ2
  • Molecular MedicineQ2

Areas: Biochemistry, Genetics and Molecular Biology · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

RNA Interference and Gene DeliveryNanoparticle-Based Drug DeliveryDrug Solubulity and Delivery SystemsDrug Transport and Resistance MechanismsNanoplatforms for cancer theranosticsAdvanced Drug Delivery SystemsAdvanced biosensing and bioanalysis techniquesCrystallization and Solubility StudiesMonoclonal and Polyclonal Antibodies ResearchRadiopharmaceutical Chemistry and Applications

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs040080012001600

Documents per Year

202220250150300450600

Detailed Information

ISSN

1543-8384, 1543-8392

SJR Best Quartile

Q1

Region

Northern America

Citations per Document (2 years)

4.86

References per Document

62.29

Coverage

2004-2026

Scope

Molecular Pharmaceutics publishes the results of original research that contributes significantly to the molecular mechanistic understanding of drug delivery and drug delivery systems. The journal encourages contributions describing research at the interface of drug discovery and drug development. Scientific areas within the scope of the journal include physical and pharmaceutical chemistry, biochemistry and biophysics, molecular and cellular biology, and polymer and materials science as they relate to drug and drug delivery system efficacy. Mechanistic Drug Delivery and Drug Targeting research on modulating activity and efficacy of a drug or drug product is within the scope of Molecular Pharmaceutics. Theoretical and experimental peer-reviewed research articles, communications, reviews, and perspectives are welcomed.

Metrics from SCImago Journal Rank 2025. View on SCImago